Urinary System Carcinoma — Trials

Urinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,398 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 672
Recruiting: 354
Ph III recruiting: 41
Growth YoY: +14.7%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (392)

clinicaltrialsPublishedShowing 251–300 of 900 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04200963	A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma	completed	Phase 1	78	Ikena OncologyINDUSTRY	1	Mar 15, 2024	clinicaltrials
NCT02156895	Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea	completed	—	111	PfizerINDUSTRY	1	Mar 8, 2024	clinicaltrials